Icahn group says goal to fix, not sell, Biogen

NEW YORK (Reuters) – Billionaire investor Carl Icahn, who has launched his second proxy battle for board representation at Biogen Idec Inc , is not aiming to sell the company, only to fix it, according to an associate.

Leave a Reply